A natriuretic peptides clearance receptor’s agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure
- Resource Type
- Short Communication
- Source
- In
Biomedicine & Pharmacotherapy September 2017 93:1144-1150 - Subject
- Language
- ISSN
- 0753-3322